Roche Holding AG
SIX:ROG
Roche Holding AG
Free Cash Flow
Roche Holding AG
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Free Cash Flow
CHf5.2B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-9%
|
|
Novartis AG
SIX:NOVN
|
Free Cash Flow
$11.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
Altamira Therapeutics Ltd
NASDAQ:CYTO
|
Free Cash Flow
CHf-10.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Free Cash Flow
$-13.9m
|
CAGR 3-Years
-318%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Free Cash Flow
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Free Cash Flow?
Free Cash Flow
5.2B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Free Cash Flow amounts to 5.2B CHF.
What is Roche Holding AG's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-9%
Over the last year, the Free Cash Flow growth was -60%. The average annual Free Cash Flow growth rates for Roche Holding AG have been -21% over the past three years , -17% over the past five years , and -9% over the past ten years .